Eribulin Mesylate Injection News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eribulin mesylate injection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eribulin Mesylate Injection Today - Breaking & Trending Today

Gland Pharma shares fall 6% as ex-promoter likely sells stake in block deals

Shares of Gland Pharma dropped 6% to Rs 1,745 on BSE as entities related to ex-promoter Dr Ravi Penmetsa sold 5.5% equity. Large block deals of 91 lakh shares worth Rs 1,600 crore reported. ....

Ravi Penmetsa , Nicomac Machinery Rp Advisory Services , Axis Bank , Gland Pharma , Bain Capital , Eribulin Mesylate Injection , Gland Pharma Share Price , Gland Pharma Stock Price , Gland Pharma Stock News , Gland Pharma Block Deal ,

Gland Pharma's Eribulin Mesylate Injection Approved by FDA for Cancer Treatment

The approval from the USFDA positions the product as the first generic approval on the market, representing a milestone achievement for Gland Pharma. ....

United States , Andhra Pradesh , Orbicular Pharmaceutical Technologies Private , Drug Administration , Gland Pharma , Eribulin Mesylate Injection , United States Food , Eribulin Mesylate ,

Stocks in news: Stocks in news: Nestle India, Titan, Vodafone Idea, Wipro, Tata Steel

The Board of Nestle India approved paying a royalty fee to its parent company Nestle S.A. The payment will be made at a rate of up to 5.25% of total net sales and it is payable in a staggered manner over five years. ....

Thierry Delaporte , Aurobindo Pharma , Chandra Shekhar Ghosh , T Vijaya Kumar , Cochin Shipyard , Us Navy , Titan Co , Tata Steel , Bandhan Bank , Nestle India , Vodafone Idea , Chief Executive Officer , Eribulin Mesylate Injection , Breast Cancer , Military Sealift , Stride Pharma , Shekhar Ghosh , Real Estate ,